News from discovery laboratories, inc

Jun 17, 2014, 08:30 ET

Discovery Labs Receives $1.9 Million Fast Track SBIR Grant from the National Institutes of Health (NIH) to Support AEROSURF® Phase 2a Clinical Study

 Discovery Laboratories, Inc. (NASDAQ: DSCO) today announced that it has been awarded the final $1.9 million of a $2.4 million Fast Track Small...

May 20, 2014, 10:00 ET

Discovery Labs Recruits Top Talent to Strengthen Scientific Leadership Team

Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care,...

May 08, 2014, 07:15 ET

Discovery Labs Reports First Quarter 2014 Financial Results

 Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical...

May 07, 2014, 07:30 ET

Discovery Labs Expands Exclusivity Portfolio with Three New US Patents

 Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical...

May 06, 2014, 07:30 ET

Discovery Labs to Report 2014 First Quarter Financial Results and Hold Conference Call on Thursday, May 8, 2014

 Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory...

Mar 25, 2014, 07:45 ET

Discovery Labs Announces New Appointments to Management Team

 Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical...

Mar 13, 2014, 07:45 ET

Discovery Labs Reports Fourth Quarter 2013 Financial Results

 Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical...

Mar 11, 2014, 08:00 ET

Discovery Labs to Report 2013 Fourth Quarter Financial Results and Hold Conference Call on Thursday, March 13, 2014

Discovery Laboratories, Inc. (Nasdaq: DSCO),  a specialty biotechnology company dedicated to advancing a new standard of respiratory critical...

Nov 21, 2013, 07:45 ET

Discovery Labs to Present at the 25th Annual Piper Jaffray Health Care Conference

 Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical...

Nov 12, 2013, 16:50 ET

Discovery Labs Reports Third Quarter 2013 Financial Results

 Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical...

Nov 12, 2013, 16:05 ET

Discovery Labs Receives FDA Clearance of IND to Initiate AEROSURF® Phase 2 Clinical Program

Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care,...

Nov 08, 2013, 08:30 ET

Discovery Labs to Host Conference Call to Discuss Third Quarter 2013 Results on Wednesday, November 13, 2013

 Discovery Laboratories, Inc. (Nasdaq: DSCO),  a specialty biotechnology company dedicated to advancing a new standard of respiratory...

Nov 08, 2013, 08:00 ET

Discovery Labs Announces U.S. Commercial Launch of SURFAXIN® (lucinactant)

 Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical...

Nov 05, 2013, 16:05 ET

Discovery Labs Announces Completion of $50 Million Public Offering

Discovery Laboratories, Inc. (NASDAQ: DSCO) today announced that it has completed its previously announced public offering to sell an aggregate of...

Oct 31, 2013, 08:30 ET

Discovery Labs Prices $50 Million Public Offering of Common Stock

 Discovery Laboratories, Inc. (NASDAQ: DSCO) today announced that it has priced an underwritten public offering of 25 million shares of its...

Oct 30, 2013, 16:01 ET

Discovery Labs Announces Proposed Public Offering of Common Stock

 Discovery Laboratories, Inc. (Nasdaq: DSCO) today announced that it is offering to sell shares of its common stock in an underwritten public...

Oct 17, 2013, 07:45 ET

Discovery Labs Announces IND Submission for AEROSURF®

 Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical...

Oct 08, 2013, 07:45 ET

Discovery Labs Announces Notice of Allowance for a U.S. Patent Supporting the AEROSURF® Development Program

Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care,...

Oct 04, 2013, 07:45 ET

Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications

 Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical...

Sep 05, 2013, 08:00 ET

Discovery Labs to Present at Stifel Healthcare Conference 2013

 Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
ReportBuyer
Analysts Review